Caleb Lareau is a Founding Scientist and leads the Platform Technologies group at Cartography Biosciences, focusing on the development and application of new methods for accelerating next-generation antigen discovery. Caleb completed his graduate studies at Harvard Medical School and more recently is a Stanford Science Fellow and Scholar at the Parker Institute for Cancer Immunotherapy.
This person is not in any offices